These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20111920)

  • 21. Influence of testosterone gel treatment on spermatogenesis in men with hypogonadism.
    George M; Yulia T; Svetlana K
    Gynecol Endocrinol; 2014 Oct; 30 Suppl 1():22-4. PubMed ID: 25200823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Testosterone replacement therapy in male late onset hypogonadism: available pharmacological strategies.
    Turchi P; Simi S; Pescatori ES
    J Endocrinol Invest; 2005; 28(11 Suppl Proceedings):61-8. PubMed ID: 16760628
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Testosterone and the prostate].
    Sperling H; Rossi R; Lümmen G; Rübben H
    Urologe A; 2004 Sep; 43(9):1092-6. PubMed ID: 15368045
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Testosterone release from a subcutaneous, biodegradable microcapsule formulation (Viatrel) in hypogonadal men.
    Amory JK; Anawalt BD; Blaskovich PD; Gilchriest J; Nuwayser ES; Matsumoto AM
    J Androl; 2002; 23(1):84-91. PubMed ID: 11780927
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment options for a patient experiencing pruritic rash associated with transdermal testosterone: a review of the literature.
    McGriff NJ; Csako G; Kabbani M; Diep L; Chrousos GP; Pucino F
    Pharmacotherapy; 2001 Nov; 21(11):1425-35. PubMed ID: 11714217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Randomized cross-over clinical trial of injectable vs. implantable depot testosterone for maintenance of testosterone replacement therapy in androgen deficient men.
    Fennell C; Sartorius G; Ly LP; Turner L; Liu PY; Conway AJ; Handelsman DJ
    Clin Endocrinol (Oxf); 2010 Jul; 73(1):102-9. PubMed ID: 19891698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and pharmacodynamics of subcutaneous testosterone implants in hypogonadal men.
    Jockenhövel F; Vogel E; Kreutzer M; Reinhardt W; Lederbogen S; Reinwein D
    Clin Endocrinol (Oxf); 1996 Jul; 45(1):61-71. PubMed ID: 8796140
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence-based medicine update on testosterone replacement therapy (TRT) in male hypogonadism: focus on new formulations.
    Giagulli VA; Triggiani V; Corona G; Carbone D; Licchelli B; Tafaro E; Resta F; Sabbà C; Maggi M; Guastamacchia E
    Curr Pharm Des; 2011; 17(15):1500-11. PubMed ID: 21521164
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Injection of testosterone may be safer and more effective than transdermal administration for combating loss of muscle and bone in older men.
    Borst SE; Yarrow JF
    Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1035-42. PubMed ID: 25898953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HDL cholesterol subfractions and the effect of testosterone replacement in hypogonadism.
    Bolu E; Sonmez A; Tapan S; Taslipinar A; Aydogdu A; Meric C; Basaran Y; Uckaya G; Serdar M; Kurt I; Azal O
    Horm Metab Res; 2013 Jun; 45(6):443-8. PubMed ID: 23613012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Andropause].
    Hochreiter WW; Ackermann DK; Brütsch HP
    Ther Umsch; 2005 Dec; 62(12):821-6. PubMed ID: 16405287
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Testosterone replacement therapy.
    Jones TH
    Br J Hosp Med (Lond); 2007 Oct; 68(10):547-53. PubMed ID: 17974303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The latest options and future agents for treating male hypogonadism.
    Edelstein D; Sivanandy M; Shahani S; Basaria S
    Expert Opin Pharmacother; 2007 Dec; 8(17):2991-3008. PubMed ID: 18001258
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of testosterone gel in the treatment of male hypogonadism.
    Lakshman KM; Basaria S
    Clin Interv Aging; 2009; 4():397-412. PubMed ID: 19966909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Testosterone deficiency and replacement.
    Howell S; Shalet S
    Horm Res; 2001; 56 Suppl 1():86-92. PubMed ID: 11786693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of implantation site and track geometry on the extrusion rate and pharmacology of testosterone implants.
    Kelleher S; Conway AJ; Handelsman DJ
    Clin Endocrinol (Oxf); 2001 Oct; 55(4):531-6. PubMed ID: 11678837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Testosterone replacement therapy for older men.
    Wald M; Meacham RB; Ross LS; Niederberger CS
    J Androl; 2006; 27(2):126-32. PubMed ID: 16474018
    [No Abstract]   [Full Text] [Related]  

  • 38. Testosterone deficiency in older men: a problem worth treating.
    McHenry Martin C
    Consult Pharm; 2012 Mar; 27(3):152-63. PubMed ID: 22421515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Advances in male hormone substitution therapy.
    Qoubaitary A; Swerdloff RS; Wang C
    Expert Opin Pharmacother; 2005 Aug; 6(9):1493-506. PubMed ID: 16086637
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transdermal testosterone.
    McClellan KJ; Goa KL
    Drugs; 1998 Feb; 55(2):253-8; discussion 259. PubMed ID: 9506244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.